Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation: Rertrospective observational trial | Zendy

Hadeel Samarkandi | Zendy; Mohammad Al Nahedh | Zendy; Areej Alfattani | Zendy; F Alsharif | Zendy; Nasir Bakshi | Zendy; Walid Rasheed | Zendy; Feras Alfraih | Zendy; Mohammed K. Alhumaid | Zendy; Nora Alkhudair | Zendy; Saud Alhayli | Zendy; Hawazen Saleh Alsaedi | Zendy; Marwan Shaheen | Zendy; Amr Hanbali | Zendy; Shahrukh K. Hashmi | Zendy; Edward Devol | Zendy; Amal Al-Seraihy | Zendy; Hazzaa Alzahrani | Zendy; Mahmoud Aljurf | Zendy

Open Access

Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation: Rertrospective observational trial

Author(s) -

Hadeel Samarkandi,

Mohammad Al Nahedh,

Areej Alfattani,

F Alsharif,

Nasir Bakshi,

Walid Rasheed,

Feras Alfraih,

Mohammed K. Alhumaid,

Nora Alkhudair,

Saud Alhayli,

Hawazen Saleh Alsaedi,

Marwan Shaheen,

Amr Hanbali,

Shahrukh K. Hashmi,

Edward Devol,

Amal Al-Seraihy,

Hazzaa Alzahrani,

Mahmoud Aljurf

Publication year - 2020

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2020.07.006

Subject(s) - eltrombopag , observational study , hematopoietic cell , medicine , hematopoietic stem cell transplantation , transplantation , randomized controlled trial , haematopoiesis , oncology , intensive care medicine , immune thrombocytopenia , platelet , biology , stem cell , genetics

Thrombocytopenia remains a life-threatening late complication of HCT with an incidence of 5-20%. Currently, there is no approved drug for the treatment of persistent thrombocytopenia post HCT and platelet transfusion is the maintain stay of treatment. Eltrombopag is approved for the treatment of thrombocytopenia associated with different diseases, however; data on eltrombopag treatment post HCT are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research